We noted that in addition to regulators of CDK1 target phosphorylation such as CDC25C and MAST-L, CDK2 mRNA levels are lower in CHH patient cells, whereas mRNA for the potent CDK inhibitor CDKN1A is upregulated. This evidence concerns the gene CDKN1A and cartilage-hair hypoplasia.